Kin Shi Asia Pharmaceuticals: Director Zheng Zhiyong and shareholder Jiang Euchen reduced their holdings by 0.06% and 0.02% respectively.

Jinshiya Pharmaceuticals announced that the company's director, Zheng Zhiyong, and shareholder Jiang Erchen have completed their planned share reduction. Zheng Zhiyong reduced 240,000 shares through centralized bidding from December 26, 2025 to January 22, 2026, at an average price of 10.9 yuan per share, accounting for 0.06% of the total share capital; Jiang Erchen reduced 70,000 shares through centralized bidding on November 26, 2025, at an average price of 13.18 yuan per share, accounting for 0.02% of the total share capital. After the reduction, Zheng Zhiyong holds 3.4653 million shares, accounting for 0.86%; Jiang Erchen holds 157,000 shares, accounting for 0.04%.